Icon dials back its guidance after posting modest sales growth

Icon ($ICLR) is again reducing its revenue expectations for 2015 but increasing its profit guidance, counting on a big quarter of business wins to balance some sluggish backlog conversion.

Revenue came in at $388.7 million in the second quarter, a 3.4% increase in real dollars and a 9% jump in constant currency. The total falls short of analyst estimates, which had Icon grossing about $403 million on the quarter, according to Zacks. However, the CRO's profits soared 44% to $58.6 million.

Icon is now reducing its full-year revenue expectations by about 3% at midpoint, looking for about $1.6 billion, to account for some difficulties turning backlogged orders into bookable sales, the company said. At the same time, the Irish contractor is increasing its 2015 earnings guidance by 9%.

Despite the revenue misstep, Icon believes it's still on track for a big year. The company pulled in a record $486 million in new business last quarter, boosting its backlog by 8% and giving it a book-to-bill ratio of 1.25.

- read the results

Suggested Articles

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.

Aetion has raised $50 million so far, and it plans to enhance its platform to support more complex therapeutic areas and expand its team.

Charles River partners with PathoQuest to offer clients NGS solutions for biologics viral contamination testing and cell-line genetic characterization.